Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 3/2019

01.02.2017 | Original Article

Is ‘Group and Save’ Blood Request Routinely Required for Nasopharyngeal Biopsy?

verfasst von: Foster Tochukwu Orji, Nekwu E. Okolugbo

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives To establish our current practice of ‘group and save’ blood for nasopharyngeal tumour biopsy (NB), and to determine the rate of blood transfusions among patients who underwent NB under general anaesthesia. Methods A retrospective chart review of all patients who underwent biopsy of NB in our tertiary institution between January 2006 and December 2015 was undertaken. Those with Juvenile nasopharyngeal angiofibroma were excluded. Data retrieved included patients’ characteristics such as age/sex, anaemia, primary tumour extension, and histology. Outcome measures included rate of ‘group and save blood’ requests, intra-operative blood loss, blood transfusion rates. Comparison was made between those that were requested to group and save blood prior to surgery (group ‘A’) and the group ‘B’ that were not so requested. Results We analysed eligible 103 cases (71 males and 32 females) out of 121 nasopharyngeal biopsies over the study period. ‘Group and save’ blood was undertaken in 47.6% (49/103) of our patients. Only 12.2% of the requested blood was transfused. Among evaluated patient characteristics, only oropharyngeal tumour extension differ between the study groups (P = 0.025). Overall, 14% had significant intra-operative blood loss (>500 ml), while 9.7% were transfused. The rates of blood loss and transfusion were not significantly different between the study groups (P = 0.22 and 0.09 respectively). Significant factors that influenced transfusion were pre-operative anaemia and oropharyngeal tumour extension. Conclusion There was high rate of arbitrary request for ‘group and save blood’ prior to NB in our institution over the last decade, which seems largely unnecessary. We recommend it be undertaken only in the presence anaemia and extensive oropharyngeal tumour extension.
Literatur
1.
Zurück zum Zitat Romani R, Tuominen H, Hernesniemi J (2010) Reducing intraoperative bleeding of juvenile nasopharyngeal angiofibroma. World Neurosug 74:497–500CrossRef Romani R, Tuominen H, Hernesniemi J (2010) Reducing intraoperative bleeding of juvenile nasopharyngeal angiofibroma. World Neurosug 74:497–500CrossRef
2.
Zurück zum Zitat Yüce S, Uysal IO, Doğan M, Polat K, Şalk I, Müderris S (2013) A giant juvenile nasopharyngeal angiofibroma. J Craniofac Surg 24:207–209 Yüce S, Uysal IO, Doğan M, Polat K, Şalk I, Müderris S (2013) A giant juvenile nasopharyngeal angiofibroma. J Craniofac Surg 24:207–209
3.
Zurück zum Zitat Li Z, Lin C, Lin G, Fang Z (2010) Study and analysis on the hemorrhage of pterygoid venous plexus in large nasopharyngeal angiofibroma resection. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24:244–246PubMed Li Z, Lin C, Lin G, Fang Z (2010) Study and analysis on the hemorrhage of pterygoid venous plexus in large nasopharyngeal angiofibroma resection. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24:244–246PubMed
4.
Zurück zum Zitat da Lilly-Tariah OB, Somefun AO (2003) Malignant tumours of the nasopharynx at Jos University Teaching Hospital. Niger Postgrad Med J 10:99–102PubMed da Lilly-Tariah OB, Somefun AO (2003) Malignant tumours of the nasopharynx at Jos University Teaching Hospital. Niger Postgrad Med J 10:99–102PubMed
5.
Zurück zum Zitat Brugere J, Point D, Sancho-Garnier H, Schwaab G (1978) Epidemiology of malignant tumours of the nasopharynx in France: retrospective and prospective studies. IARC Sci Publ 20:241–249 Brugere J, Point D, Sancho-Garnier H, Schwaab G (1978) Epidemiology of malignant tumours of the nasopharynx in France: retrospective and prospective studies. IARC Sci Publ 20:241–249
6.
Zurück zum Zitat Bove JR (1987) Transfusion-associated hepatitis and AIDS. What is the risk? N Engl J Med 317:242–245CrossRef Bove JR (1987) Transfusion-associated hepatitis and AIDS. What is the risk? N Engl J Med 317:242–245CrossRef
7.
Zurück zum Zitat de Stasio G (1992) Transfusion risks and alternatives to transfusion. Recenti Prog Med 83:321–329PubMed de Stasio G (1992) Transfusion risks and alternatives to transfusion. Recenti Prog Med 83:321–329PubMed
8.
Zurück zum Zitat Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP et al (2007) Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83:S27–S86CrossRef Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP et al (2007) Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83:S27–S86CrossRef
9.
Zurück zum Zitat Rohling RG, Haers PE, Zimmermann AP, Schanz U, Marquetand R, Sailer HF (1999) Multimodal strategy for reduction of homologous transfusions in cranio-maxillofacial surgery. Int J Oral Maxillofac Surg 28:137–142CrossRef Rohling RG, Haers PE, Zimmermann AP, Schanz U, Marquetand R, Sailer HF (1999) Multimodal strategy for reduction of homologous transfusions in cranio-maxillofacial surgery. Int J Oral Maxillofac Surg 28:137–142CrossRef
10.
Zurück zum Zitat Katz E, Gaitini L, Samri M, Egoz N, Fergusson D et al (2001) The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel. Isr Med Assoc J 3:809–812PubMed Katz E, Gaitini L, Samri M, Egoz N, Fergusson D et al (2001) The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel. Isr Med Assoc J 3:809–812PubMed
11.
Zurück zum Zitat Graham ID, Fergusson D, McAuley L, Laupacis A (2000) The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals. Int J Technol Assess Health Care 16:228–241CrossRef Graham ID, Fergusson D, McAuley L, Laupacis A (2000) The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals. Int J Technol Assess Health Care 16:228–241CrossRef
Metadaten
Titel
Is ‘Group and Save’ Blood Request Routinely Required for Nasopharyngeal Biopsy?
verfasst von
Foster Tochukwu Orji
Nekwu E. Okolugbo
Publikationsdatum
01.02.2017
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 3/2019
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-017-1078-5

Weitere Artikel der Sonderheft 3/2019

Indian Journal of Otolaryngology and Head & Neck Surgery 3/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.